Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients (Greenpep)

This study has been completed.
Sponsor:
Collaborator:
Brahms AG
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01126554
First received: May 17, 2010
Last updated: April 28, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)